Drug-Induced Liver Injury Pattern Assessment with Calculation of R Value
Also known as: Drug, Herbal, and Dietary Supplements Induced Liver Injury
Use
This test is used for initial laboratory assessment of drug, herbal and dietary supplement-induced liver injury.
Special Instructions
Not provided.
Limitations
Grossly hemolyzed samples can generate spurious results, while increased ALT levels are observed in obesity, potentially affecting the interpretation. For optimal results, specimens should not be frozen as oxalate, EDTA, or citrate plasma can interfere with the assessment. Proper labeling and handling are crucial to avoid rejection or erroneous results.
Methodology
Other
Biomarkers
Alkaline Phosphatase
AnalyteALT (SGPT)
AnalyteDILI R Value
Analyte
LOINC Codes
- 6768-6 - ALP SerPl-cCnc
- 1742-6 - ALT SerPl-cCnc
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.7 mL
Container
Red-top tube, gel-barrier tube or green-top (lithium heparin) tube; do not use oxalate, EDTA or citrate plasma
Collection Instructions
Separate serum or plasma from cells within 45 minutes of collection.
Storage Instructions
Maintain specimen at room temperature.
Causes for Rejection
Gross hemolysis; excessive lipemia; improper labeling
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
Other tests from different labs that may be relevant